My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 943

    1.

    Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes.

    Kahn SE, Zinman B, Haffner SM, O'Neill MC, Kravitz BG, Yu D, Freed MI, Herman WH, Holman RR, Jones NP, Lachin JM, Viberti GC; ADOPT Study Group.

    Diabetes. 2006 Aug;55(8):2357-64.PMID: 16873701 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Metabolic syndrome accompanied by hypercholesterolemia is strongly associated with proinflammatory state and impairment of fibrinolysis in patients with type 2 diabetes: synergistic effects of plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor.

    Aso Y, Wakabayashi S, Yamamoto R, Matsutomo R, Takebayashi K, Inukai T.

    Diabetes Care. 2005 Sep;28(9):2211-6.PMID: 16123492 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes.

    Temelkova-Kurktschiev T, Siegert G, Bergmann S, Henkel E, Koehler C, Jaross W, Hanefeld M.

    Metabolism. 2002 Jun;51(6):743-9.PMID: 12037728 [PubMed - indexed for MEDLINE]Related articles

    4.

    Adiponectin and C-reactive protein in obesity, type 2 diabetes, and monodrug therapy.

    Putz DM, Goldner WS, Bar RS, Haynes WG, Sivitz WI.

    Metabolism. 2004 Nov;53(11):1454-61.PMID: 15536601 [PubMed - indexed for MEDLINE]Related articles

    5.

    Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study.

    Han TS, Sattar N, Williams K, Gonzalez-Villalpando C, Lean ME, Haffner SM.

    Diabetes Care. 2002 Nov;25(11):2016-21.PMID: 12401749 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    C-reactive protein is elevated in obese patients with the metabolic syndrome.

    Florez H, Castillo-Florez S, Mendez A, Casanova-Romero P, Larreal-Urdaneta C, Lee D, Goldberg R.

    Diabetes Res Clin Pract. 2006 Jan;71(1):92-100. Epub 2005 Jul 5.PMID: 16002176 [PubMed - indexed for MEDLINE]Related articles

    7.

    Relationship between adipokines, inflammation, and vascular reactivity in lean controls and obese subjects with metabolic syndrome.

    Bahia L, Aguiar LG, Villela N, Bottino D, Godoy-Matos AF, Geloneze B, Tambascia M, Bouskela E.

    Clinics (Sao Paulo). 2006 Oct;61(5):433-40.PMID: 17072441 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    C-reactive protein and metabolic syndrome in youth: a strong relationship?

    Oliveira AC, Oliveira AM, Adan LF, Oliveira NF, Silva AM, Ladeia AM.

    Obesity (Silver Spring). 2008 May;16(5):1094-8. Epub 2008 Mar 6. Retraction in: Oliveira AC, Oliveira AM, Adan LF, Oliveira NF, Silva AM, Ladeia AM. Obesity (Silver Spring). 2009 Jun;17(6):1113. PMID: 18356840 [PubMed - indexed for MEDLINE]Related articles

    9.

    Cardiometabolic risk among African American women: a pilot study.

    Appel SJ, Oster RA, Floyd NA, Ovalle F.

    J Cardiovasc Nurs. 2009 Mar-Apr;24(2):140-50.PMID: 19242280 [PubMed - indexed for MEDLINE]Related articles

    10.

    The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease.

    Oh SY, Cho YK, Kang MS, Yoo TW, Park JH, Kim HJ, Park DI, Sohn CI, Jeon WK, Kim BI, Son BH, Shin JH.

    Metabolism. 2006 Dec;55(12):1604-9.PMID: 17142131 [PubMed - indexed for MEDLINE]Related articles

    11.

    Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox.

    Meis SB, Schuster D, Gaillard T, Osei K.

    Ethn Dis. 2006 Autumn;16(4):830-6.PMID: 17061734 [PubMed - indexed for MEDLINE]Related articles

    12.

    Distribution and metabolic syndrome correlates of plasma C-reactive protein in biracial (black-white) younger adults: the Bogalusa Heart Study.

    Patel DA, Srinivasan SR, Xu JH, Li S, Chen W, Berenson GS.

    Metabolism. 2006 Jun;55(6):699-705.PMID: 16713426 [PubMed - indexed for MEDLINE]Related articles

    13.

    Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome.

    Derosa G, Gaddi AV, Piccinni MN, Ciccarelli L, Salvadeo S, Peros E, Ghelfi M, Ferrari I, Cicero AF.

    Pharmacotherapy. 2005 May;25(5):637-45.PMID: 15899724 [PubMed - indexed for MEDLINE]Related articles

    14.

    Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.

    Festa A, D'Agostino R Jr, Tracy RP, Haffner SM; Insulin Resistance Atherosclerosis Study.

    Diabetes. 2002 Apr;51(4):1131-7.PMID: 11916936 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren.

    Holst-Schumacher I, Nuñez-Rivas H, Monge-Rojas R, Barrantes-Santamaría M.

    Food Nutr Bull. 2009 Jun;30(2):161-70.PMID: 19689095 [PubMed - indexed for MEDLINE]Related articles

    16.

    Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.

    De Pergola G, De Mitrio V, Sciaraffia M, Pannacciulli N, Minenna A, Giorgino F, Petronelli M, Laudadio E, Giorgino R.

    Metabolism. 1997 Nov;46(11):1287-93.PMID: 9361687 [PubMed - indexed for MEDLINE]Related articles

    17.

    Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome.

    Valle M, Martos R, Gascón F, Cañete R, Zafra MA, Morales R.

    Diabetes Metab. 2005 Feb;31(1):55-62.PMID: 15803114 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Associations of resistin with inflammatory and fibrinolytic markers, insulin resistance, and metabolic syndrome in middle-aged and older Chinese.

    Qi Q, Wang J, Li H, Yu Z, Ye X, Hu FB, Franco OH, Pan A, Liu Y, Lin X.

    Eur J Endocrinol. 2008 Nov;159(5):585-93. Epub 2008 Aug 27.PMID: 18753313 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.

    Gürlek A, Bayraktar M, Kirazli S.

    Diabetes Care. 2000 Jan;23(1):88-92.PMID: 10857975 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Does C-reactive protein identify a subclinical metabolic disease in healthy subjects?

    Bo S, Gambino R, Uberti B, Mangiameli MP, Colosso G, Repetti E, Gentile L, Cassader M, Pagano GF.

    Eur J Clin Invest. 2005 Apr;35(4):265-70.PMID: 15816996 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity